|
|
NuProbe develops ultra-sensitive and highly multiplexed assays for non-invasive cancer profiling on NGS and qPCR / Sanger. NuProbe takes <a href="https://www.nuprobe.com/">Pan-Cancer NGS Panel</a> a multi-platform approach to use its breakthrough technologies in genomics allow diseases to be detected, treated, and cured at early stages for better outcomes with lower costs.